Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging study.
Ochi R, Noda Y, Tsuchimoto S, Tarumi R, Honda S, Matsushita K, Tsugawa S, Plitman E, Masuda F, Ogyu K, Wada M, Miyazaki T, Fujii S, Chakravarty MM, Graff-Guerrero A, Uchida H, Mimura M, Nakajima S. Ochi R, et al. Among authors: masuda f. Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jun 8;100:109871. doi: 10.1016/j.pnpbp.2020.109871. Epub 2020 Jan 18. Prog Neuropsychopharmacol Biol Psychiatry. 2020. PMID: 31962187
Effectiveness of the prefrontal repetitive transcranial magnetic stimulation on cognitive profiles in depression, schizophrenia, and Alzheimer's disease: A systematic review.
Iimori T, Nakajima S, Miyazaki T, Tarumi R, Ogyu K, Wada M, Tsugawa S, Masuda F, Daskalakis ZJ, Blumberger DM, Mimura M, Noda Y. Iimori T, et al. Among authors: masuda f. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jan 10;88:31-40. doi: 10.1016/j.pnpbp.2018.06.014. Epub 2018 Jun 25. Prog Neuropsychopharmacol Biol Psychiatry. 2019. PMID: 29953934
Neural correlates of delay discount alterations in addiction and psychiatric disorders: A systematic review of magnetic resonance imaging studies.
Noda Y, Barr MS, ElSalhy M, Masuda F, Tarumi R, Ogyu K, Wada M, Tsugawa S, Miyazaki T, Nakajima S, Mimura M. Noda Y, et al. Among authors: masuda f. Prog Neuropsychopharmacol Biol Psychiatry. 2020 Apr 20;99:109822. doi: 10.1016/j.pnpbp.2019.109822. Epub 2019 Nov 18. Prog Neuropsychopharmacol Biol Psychiatry. 2020. PMID: 31751662
Early improvements of individual symptoms as a predictor of treatment response to asenapine in patients with schizophrenia.
Ogyu K, Noda Y, Yoshida K, Kurose S, Masuda F, Mimura Y, Nishida H, Plitman E, Tarumi R, Tsugawa S, Wada M, Miyazaki T, Uchida H, Graff-Guerrero A, Mimura M, Nakajima S. Ogyu K, et al. Among authors: masuda f. Neuropsychopharmacol Rep. 2020 Jun;40(2):138-149. doi: 10.1002/npr2.12103. Epub 2020 Mar 16. Neuropsychopharmacol Rep. 2020. PMID: 32180369 Free PMC article. Clinical Trial.
Thalamic and striato-pallidal volumes in schizophrenia patients and individuals at risk for psychosis: A multi-atlas segmentation study.
Takahashi T, Tsugawa S, Nakajima S, Plitman E, Chakravarty MM, Masuda F, Wada M, Kurose S, Ochi R, Matsushita K, Sasabayashi D, Nakamura M, Nishikawa Y, Takayanagi Y, Nishiyama S, Higuchi Y, Mizukami Y, Furuichi A, Kido M, Hashimoto R, Noguchi K, Fujii S, Mimura M, Noda Y, Suzuki M. Takahashi T, et al. Among authors: masuda f. Schizophr Res. 2022 May;243:268-275. doi: 10.1016/j.schres.2020.04.016. Epub 2020 May 21. Schizophr Res. 2022. PMID: 32448678
Glutathione levels and activities of glutathione metabolism enzymes in patients with schizophrenia: A systematic review and meta-analysis.
Tsugawa S, Noda Y, Tarumi R, Mimura Y, Yoshida K, Iwata Y, Elsalhy M, Kuromiya M, Kurose S, Masuda F, Morita S, Ogyu K, Plitman E, Wada M, Miyazaki T, Graff-Guerrero A, Mimura M, Nakajima S. Tsugawa S, et al. Among authors: masuda f. J Psychopharmacol. 2019 Oct;33(10):1199-1214. doi: 10.1177/0269881119845820. Epub 2019 Apr 30. J Psychopharmacol. 2019. PMID: 31039654
Resting-State Isolated Effective Connectivity of the Cingulate Cortex as a Neurophysiological Biomarker in Patients with Severe Treatment-Resistant Schizophrenia.
Wada M, Nakajima S, Tarumi R, Masuda F, Miyazaki T, Tsugawa S, Ogyu K, Honda S, Matsushita K, Kikuchi Y, Fujii S, Blumberger DM, Daskalakis ZJ, Mimura M, Noda Y. Wada M, et al. Among authors: masuda f. J Pers Med. 2020 Aug 14;10(3):89. doi: 10.3390/jpm10030089. J Pers Med. 2020. PMID: 32823914 Free PMC article.
191 results